EFFICACY OF ORAL PREDNISOLONE IN MANAGEMENT OF BRONCHIOLITIS: A PLACEBO-CONTROLLED STUDY

Authors

  • F TAJ Department of Peadiatrics, Christian Hospital Taxila, Pakistan
  • M BATOOL Department of Peadiatrics, Institute Tehsil Head Quarter Hospital Phalia, Pakistan
  • M KHIZER Department of Peadiatrics, Allama Iqbal Memorial Teaching Hospital Sialkot, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.241

Keywords:

placebo, Prednisolone, infants, bronchiolitis

Abstract

Acute bronchiolitis is a common and deadly condition in infants described as a respiratory infection due to inflammatory obstruction of bronchioles. This study was designed to assess prednisolone's efficacy in treating bronchiolitis in children aged >2 years.

A retrospective study was conducted in the Department of peadiatrics in different hospitals from February 2022- February 2023. A total of 80 children aged > 2 years with acute bronchiolitis were included in the study. The patients were divided into groups A and B. Group A (n=40) was administered salbutamol combined with prednisolone, and Group B (n=40) was administered salbutamol alone. The outcomes of both treatments were evaluated.

The average age in group A and B was 6.9± 4.5 months and 5.5 ± 3.9 months, respectively. 65 patients (81.2%) belonged to middle-class families, and 20 (25%) came from crowded households. 10 patients (12.5%) had a preterm delivery, and 12 (15%) had low birth weight. A significant difference was observed in Group A after 3 days of treatment (p <0.05), and a reduction in hospital stay was also noted (p<0.001) in contrast with Group B. Based on the results, it can be concluded that the prednisolone is an effective drug in the management of bronchiolitis by reducing hospital stay and disease severity in children > 2 years.

Downloads

Download data is not yet available.

References

Ahmad, S., Shahzad, S., Khan, U. N., Shahzad, M. A., Ahmad, M., and Ahmad, M. (2019). Efficacy of corticosteroids in acute bronchiolitis: short term outcomes. Rawal Medical Journal 44, 509-509.

Ali, A., Yousafzai, M. T., Waris, R., Jafri, F., Aziz, F., Abbasi, I. N., and Zaidi, A. (2017). RSV associated hospitalizations in children in Karachi, Pakistan: implications for vaccine prevention strategies. Journal of medical virology 89, 1151-1157.

Baig, M., Anwaar, O., Hussain, M., Zahid, S., Mehmood, M., and Saleem, S. (2019). Efficacy of Prednisolone in bronchiolitis with and without family history of atopy. J Pak Med Assoc, 1.

Bozzola, E., Ciarlitto, C., Guolo, S., Brusco, C., Cerone, G., Antilici, L., Schettini, L., Piscitelli, A. L., Chiara Vittucci, A., and Cutrera, R. (2021). Respiratory syncytial virus bronchiolitis in infancy: the acute hospitalization cost. Frontiers in pediatrics 8, 594898.

Bylsma, L. C., Suh, M., Movva, N., Fryzek, J. P., and Nelson, C. B. (2022). Mortality among US infants and children under 5 years of age with respiratory syncytial virus and bronchiolitis: a systematic literature review. The Journal of Infectious Diseases 226, S267-S281.

Fernandes, R. M., Wingert, A., Vandermeer, B., Featherstone, R., Ali, S., Plint, A. C., Stang, A. S., Rowe, B. H., Johnson, D. W., and Allain, D. (2019). Safety of corticosteroids in young children with acute respiratory conditions: a systematic review and meta-analysis. BMJ open 9, e028511.

Foster, S., Cooper, M., Oosterhof, S., and Borland, M. (2018). Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine 6, 97-106.

Gelbart, B., McSharry, B., Delzoppo, C., Erickson, S., Lee, K., Butt, W., Rea, M., Wang, X., Beca, J., and Kazemi, A. (2022). Pragmatic randomized trial of corticosteroids and inhaled epinephrine for bronchiolitis in children in intensive care. The Journal of Pediatrics 244, 17-23. e1.

Hasan, K. Z., Mollah, M. A. H., Hossain, M. M., Alam, M. Z., Bhuiyan, A. S. I., Ahmed, M. F., and Khan, M. I.-u.-H. (2021). Efficacy of Prednisolone in Recovery from Acute Bronchiolitis: Study in a Tertiary Care Hospital, Dhaka, Bangladesh. American Journal of Pediatrics 7, 85.

Korppi, M., Mecklin, M., and Heikkilä, P. (2019). Review shows substantial variations in the use of medication for infant bronchiolitis between and within countries. Acta Paediatrica 108, 1016-1022.

Piedra, P. A., and Stark, A. R. (2020). Bronchiolitis in infants and children: Treatment; outcome; and prevention. UpToDate. Marzo.

Shaw, C., and Wisner, E. (2022). Pragmatic Randomized Trial of Corticosteroids and Inhaled Epinephrine for Bronchiolitis in Children in Intensive Care. Pediatrics 150, S52-S53.

Tejedor-Sojo, J., Chan, K. N., Bailey, M., Williams, A., Killgore, M., Gillard, L., Campo, M., Hua, H., and Jain, S. (2019). Improving bronchiolitis care in outpatient settings across a health care system. Pediatric Emergency Care 35, 791-798.

Downloads

Published

2023-04-17

How to Cite

TAJ , F., BATOOL , M., & KHIZER , M. (2023). EFFICACY OF ORAL PREDNISOLONE IN MANAGEMENT OF BRONCHIOLITIS: A PLACEBO-CONTROLLED STUDY. Biological and Clinical Sciences Research Journal, 2023(1), 241. https://doi.org/10.54112/bcsrj.v2023i1.241